In order to assess the acute impact of VEGF on AF susceptibility, we assessed the structural and electrophysiological impacts of treating Langendorff-perfused WT mouse hearts with clinically relevant levels of VEGF (low: 100 pg/ml and high: 500 pg/ml) for 30 min. The gene discussed is VEGFA; the disease is atrial fibrillation.